Articles tagged with: DARUNAVIR _ COBICISTAT _ EMTRICITABINE _ TENOFOVIR ALAFENAMIDE

Living with HIV? Speak out to Pharma!

published: January, 10, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, Activism, As Prevention , General Health, Treatment Guidelines -including when to start, Upcoming Events, Health, Revolving Door, Treatment, Guest Authors, Media

Patient input presents a chance for people living with HIV to have their voices heard by drug regulators

Living with HIV? Speak out to Pharma!

UPCOMING CTAC PATIENT GROUP INPUT CONSULTATIONS CTAC is calling for people living with HIV to take part in patient consultations so that they can have their voices heard by drug regulators. The first 20 attendees who complete a survey at the end of each session will recieve a $10 gift voucher. WEDNESDAY 10TH JANUARY 2018, 2:00-3:00 EST: NEW HIV MEDICATION DOLUTEGRAVIR / RILPIVIRINE  - REGISTER HERE. This informative webinar, led by CTAC Policy Researcher Amanda Fletcher, will discuss the